Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences-Reference-Cited by-同舟云学术

Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences

Published:2013-01-29 Issue:10 Volume:15 Page:780-788
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Ren Jun,Di Lijun,Song Guohong,Yu Jing,Jia Jun,Zhu Yuling,Yan Ying,Jiang Hanfang,Liang Xu,Che Li,Zhang Jie,Wan Fengling,Wang Xiaoli,Zhou Xinna,Lyerly Herbert Kim

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-013-1001-9.pdf

Reference20 articles.

1. Higgins MJ, Wolff AC (2008) Therapeutic options in the management of metastatic breast cancer. Oncology 22:614–623

2. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983–3988

3. Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5:275–284

4. Morrison BJ, Schmidt CW, Lakhani SR et al (2008) Breast cancer stem cells: implications for therapy of breast cancer. Breast Cancer Res 10:210

5. Hortobagyi GN, Spanos W, Montague ED et al (1983) Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy. Int J Radiat Oncol Biol Phys 9:643–650

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer;Biomedicine & Pharmacotherapy;2023-06

2. Prognostic value and immunological roles of GPX3 in gastric cancer;International Journal of Medical Sciences;2023

3. Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer;Journal of Oncology;2022-07-12

4. Discovering the Triad between Nav1.5, Breast Cancer, and the Immune System: A Fundamental Review and Future Perspectives;Biomolecules;2022-02-15

5. Cancer vaccines as a targeted immunotherapy approach for breast cancer: an update of clinical evidence;Expert Review of Vaccines;2022-01-06